Randomized, double-blind, placebo-controlled crossover trial of modafinil in the treatment of excessive daytime sleepiness in narcolepsy
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Seventy-five patients meeting international diagnostic criteria for narcolepsy enrolled in a 6-week, three-period, randomized, crossover, placebo-controlled trial. Patients received placebo, modafinil 200 mg, or modafinil 400 mg in divided doses (morning and noon). Evaluations occurred at baseline and at the end of each 2-week period. Compared with placebo, modafinil 200 and 400 mg significantly increased the mean sleep latency on the Maintenance of Wakefulness Test by 40% and 54%, with no significant difference between the two doses. Modafinil, 200 and 400 mg, also reduced the combined number of daytime sleep episodes and periods of severe sleepiness noted in sleep logs. The likelihood of falling asleep as measured by the Epworth Sleepiness Scale was equally reduced by both modafinil dose levels. There were no effects on nocturnal sleep initiation, maintenance, or architecture, nor were there any effects on sleep apnea or periodic leg movements. Neither dose interfered with the patients' ability to nap voluntarily during the day nor with their quantity or quality of nocturnal sleep. Modafinil produced no changes in blood pressure or heart rate in either normotensive or hypertensive patients. The only significant adverse effects were seen at the 400-mg dose, which was associated with more nausea and more nervousness than either placebo or the 200-mg dose. As little as a 200-mg daily dose of modafinil is therefore an effective and well-tolerated treatment of excessive daytime somnolence in narcoleptic persons.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitler, M. M., Gujavarty, K. S., & Browman, C. P. (1982) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(82)90142-0 · Cited by 522
Modafinil: A Double-Blind Multicentric Study
Billiard, M., Besset, A., Montplaisir, J., Laffont, F., Goldenberg, F., Weill, J. S., & Lubin, S. (1994) · Sleep · doi:10.1093/sleep/17.suppl_8.s107 · Cited by 162
Self-citationThe Distribution of Slow-Wave Sleep Across the Night: A Comparison for Infants, Children, and Adults
Bes, F., Schulz, H., Navelet, Y., & Salzarulo, P. (1991) · Sleep · doi:10.1093/sleep/14.1.5 · Cited by 100
Modafinil in Diurnal Sleepiness. A Study of 123 Patients
Laffont, F., Mayer, G. J., & Minz, M. (1994) · SLEEP · doi:10.1093/sleep/17.suppl_8.s113 · Cited by 33
Cited by
Modafinil: a review of neurochemical actions and effects on cognition
Minzenberg, M. J., & Carter, C. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301534 · Cited by 713
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
Bassetti, C. L. A., Adamantidis, A., Burdakov, D., Han, F., Gay, S., Kallweit, U., Khatami, R., Koning, F., Kornum, B. R., Lammers, G. J., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0226-9 · Cited by 646
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Hypothalamic Arousal Regions Are Activated during Modafinil-Induced Wakefulness
Scammell, T. E., Estabrooke, I. V., McCarthy, M. T., Chemelli, R. M., Yanagisawa, M., Miller, M. S., & Saper, C. B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-22-08620.2000 · Cited by 485
Rammohan, K. W. (2002) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.72.2.179 · Cited by 442
Approved and Investigational Uses of Modafinil: An Evidence-Based Review
Kumar, R. (2008) · Drugs · doi:10.2165/00003495-200868130-00003 · Cited by 415
The Epworth Sleepiness Scale may not reflect objective measures of sleepiness or sleep apnea
Chervin, R. D., & Aldrich, M. S. (1999) · Neurology · doi:10.1212/wnl.52.1.125 · Cited by 395
Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy
US Modafinil in Narcolepsy Multicenter Study Group (2000) · Neurology · doi:10.1212/wnl.54.5.1166 · Cited by 362
A Systematic Review of Modafinil: Potential Clinical Uses and Mechanisms of Action
Ballon, J. S., & Feifel, D. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0406 · Cited by 349
Narcolepsy:Clinical Features, New Pathophysiologic Insights, and Future Perspectives
Overeem, S., Mignot, E., GertvanDijk, J., & Lammers, G. J. (2001) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-200103000-00002 · Cited by 333
A randomized study of solriamfetol for excessive sleepiness in narcolepsy
Thorpy, M. J., Shapiro, C., Mayer, G., Corser, B. C., Emsellem, H., Plazzi, G., Chen, D., Carter, L. P., Wang, H., Lu, Y., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25423 · Cited by 327
Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea
PACK, A. I., BLACK, J. E., SCHWARTZ, J. R. L., & MATHESON, J. K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.9.2103032 · Cited by 324
Jasinski, D. R., & Kovačević-Ristanović, R. (2000) · Clinical Neuropharmacology · doi:10.1097/00002826-200005000-00004 · Cited by 292
The many faces of fatigue in major depressive disorder
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004729 · Cited by 288
“This is consistent with its known action of improving daytime sleepiness associated with a number of sleep disorders, including narcolepsy (Bastuji and Jouvet, 1988; Broughton et al., 1997), obstructive sleep apnoea (Pack et al., 2001) and shift-work sleep disorder (Roth and Roehrs, 1996).”
BackgroundKornum, B. R., Knudsen, S., Ollila, H. M., Pizza, F., Jennum, P. J., Dauvilliers, Y., & Overeem, S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.100 · Cited by 285
Basic Mechanisms of Sleep-Wake States
Jones, B. E. (2005) · Principles and Practice of Sleep Medicine · doi:10.1016/b0-72-160797-7/50018-5 · Cited by 282
Delayed diagnosis of narcolepsy: characterization and impact
Thorpy, M. J., & Krieger, A. C. (2014) · Sleep Medicine · doi:10.1016/j.sleep.2014.01.015 · Cited by 276
Adler, C. H., Caviness, J. N., Hentz, J. G., Lind, M., & Tiede, J. (2003) · Movement Disorders · doi:10.1002/mds.10390 · Cited by 272
Scales to assess sleep impairment in Parkinson's disease: Critique and recommendations
Högl, B., Arnulf, I., Comella, C., Ferreira, J., Iranzo, A., Tilley, B., Trenkwalder, C., Poewe, W., Rascol, O., Sampaio, C., et al. (2010) · Movement Disorders · doi:10.1002/mds.23190 · Cited by 268
Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
Wood, S., Sage, J. R., Shuman, T., & Anagnostaras, S. G. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007054 · Cited by 259
Clinical Pharmacokinetic Profile of Modafinil
Robertson, P., & Hellriegel, E. T. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342020-00002 · Cited by 256
EFNS guidelines on management of narcolepsy
Billiard, M., Bassetti, C., Dauvilliers, Y., Dolenc‐Groselj, L., Lammers, G. J., Mayer, G., Pollmächer, T., Reading, P., & Sonka, K. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01473.x · Cited by 255
KINGSHOTT, R. N., VENNELLE, M., COLEMAN, E. L., ENGLEMAN, H. M., MACKAY, T. W., & DOUGLAS, N. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.4.2005036 · Cited by 174
A double‐blind, placebo‐controlled trial of modafinil (200 mg/day) for methamphetamine dependence
Shearer, J., Darke, S., Rodgers, C., Slade, T., Van Beek, I., Lewis, J., Brady, D., McKetin, R., Mattick, R. P., & Wodak, A. (2009) · Addiction · doi:10.1111/j.1360-0443.2008.02437.x · Cited by 159
Modafinil ameliorates excessive daytime sleepiness after traumatic brain injury
Kaiser, P. R., Valko, P. O., Werth, E., Thomann, J., Meier, J., Stocker, R., Bassetti, C. L., & Baumann, C. R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd62a2 · Cited by 150
A Prospective Trial of Modafinil as an Adjunctive Treatment of Major Depression
DeBattista, C., Lembke, A., Solvason, H. B., Ghebremichael, R., & Poirier, J. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000104910.75206.b9 · Cited by 144
EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep
Vignatelli, L., Billiard, M., Clarenbach, P., Garcia‐Borreguero, D., Kaynak, D., Liesiene, V., Trenkwalder, C., & Montagna, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01410.x · Cited by 144
Dinges, D. (2003) · Sleep Medicine · doi:10.1016/s1389-9457(03)00108-4 · Cited by 132
Modafinil as Adjunct Therapy for Daytime Sleepiness in Obstructive Sleep Apnea
Schwartz, J. R. L., Hirshkowitz, M., Erman, M. K., & Schmidt-Nowara, W. (2003) · Chest · doi:10.1378/chest.124.6.2192 · Cited by 107
Modulatory Effects of Modafinil on Neural Circuits Regulating Emotion and Cognition
Rasetti, R., Mattay, V. S., Stankevich, B., Skjei, K., Blasi, G., Sambataro, F., Arrillaga-Romany, I. C., Goldberg, T. E., Callicott, J. H., Apud, J. A., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.83 · Cited by 83
(2006) · Cited by 58
HEITMANN, J., CASSEL, W., GROTE, L., BICKEL, U., HARTLAUB, U., PENZEL, T., & PETER, J. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70112-8 · Cited by 37
Metadata
- Authors
- Broughton, R. J., Fleming, J. A. E., George, C. F. P., Hill, J. D., Kryger, M. H., Moldofsky, H., Montplaisir, J. Y., Morehouse, R. L., Moscovitch, A., & Murphy, W. F.
- Venue
- Neurology
- Published
- 1997-08
- Volume
- 49
- Issue
- 2
- Pages
- 444-451
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2007702485
- Cited by
- 288
- References
- 4
- FWCI
- 5.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.